Skip to content


Learn about various aspects of treating cannabis use disorders, including clinical, training, and policy considerations. As new topics emerge, more resources and information will be added to this page. The resources cover topics from the APA Work Group on Cannabis with the Council on Addiction Psychiatry, training, practice/clinical, and legal issues from leading psychiatrists.


  • Motivational Interviewing

    This training discusses motivational Interviewing (MI) which can be viewed as the essential clinical skill for engaging patients in treatment and motivating patients to reduce substance use and to follow through with specific recommended behavioral or pharmacological treatments. This presentation provides a didactic overview of motivational interviewing in the context of the neurobiology of addiction and other addiction treatments and serves as a precursor to learning motivational interviewing for integration into clinical practice.
    The APA designates this enduring CME activity for a maximum of 0.5 AMA PRA Category 1 Credit™.
  • Comorbidity of Marijuana and Mental Health

    This training identifies marijuana use in adolescence, as a risk factor for poor educational achievement, cannabis and other substance use disorders, and psychotic disorders. This presentation provides a comprehensive overview of the comorbidities of marijuana use and mental disorders through the review and discussion of current research, statistics, and theories associated with marijuana use and mental illness.
    The APA designates this enduring CME activity for a maximum of 0.5 AMA PRA Category 1 Credits™.
  • Medical Cannabis: What Every Psychiatrist Should Know

    Use of cannabis for medicinal purposes (medical cannabis) has a centuries-long history in the United States and throughout the world but has been illegal in the U.S. at the federal level since 1937. Cannabis and all cannabinoids are classified in Schedule I of the Controlled Substances Act (CSA), meaning that they are considered to have a "high potential for abuse," "no currently accepted medical use in treatment,"" and "a lack of accepted safety for use" (21 U.S. Code § 812). This presentation will describe the difference between "prescribing" a medication under federal law vs. "recommending" or "authorizing" medical cannabis under state law, the major medical and psychiatric conditions for which medical cannabis can be recommended, the current scientific evidence supporting those indications, major side-effects associated with medical cannabis, and potential public health consequences.
    The APA designates this enduring CME activity for a maximum of 1.0 AMA PRA Category 1 Credits™.

Providers Clinical Support System (PCSS) Trainings

  • Management of Other Substance Use Disorders: Benzodiazepines Cocaine and Other Stimulants Cannabis

    This educational activity reviews other substance use disorders that often co-occur with opioid use disorder (OUD), including benzodiazepines and other tranquilizers, cocaine and stimulants, and cannabis. The presentation will also discuss principles of diagnosis and evaluation of treatment for each of these by themselves and in the context of OUD.
    In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
  • Adolescent Substance Use

    This training goes over various prevention strategies, interventions to prevent substance use disorders and substance use disorder treatment modalities are effective in adolescents. This module discusses the Screening, Brief Intervention, and Referral to Treatment (SBIRT) method, its implementation, and its success in clinical trials alone and in combination with prescribed medication for addiction.
    American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. This program is approved for up to 1 Nursing Contact Hour.

Free Trainings and Manuals from Additional Organizations

Other Notable Organizations

Medical leadership for mind, brain and body.

Join Today